Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
Psychogeriatrics ; 24(4): 924-932, 2024 Jul.
Article in English | MEDLINE | ID: mdl-38872472

ABSTRACT

BACKGROUND: Endometrioid carcinoma, originating in the endometrium glandular cells, is often detected early and treated by surgery. However, post-treatment life quality remains poorly studied, explicitly focusing on sleep quality, fatigue, and depression. METHODS: In this cross-sectional, observational study, 147 female patients with endometrioid-type endometrial carcinoma were evaluated using standardised tools-Pittsburgh Sleep Quality Index (PSQI), Fatigue Assessment Scale (FAS), and Beck Depression Inventory (BDI). Patients were categorised based on sleep quality and depression levels. The study employed correlation and regression analyses to examine the relationships among these variables. RESULTS: No correlations were found between sociodemographic or lifestyle variables and sleep quality, fatigue, or depression (P > 0.05). A strong correlation was identified between PSQI and FAS (r = 0.623; P < 0.001), PSQI and BDI (r = 0.291; P < 0.001), and FAS and BDI (r = 0.413; P < 0.001). Fatigue and tumour grade were potential predictors of poor sleep. Sleep quality and depression predicted fatigue, while only fatigue was a predictor for depression. Radiotherapy and external radiation rates were notably higher in the mild depression group. CONCLUSIONS: Our study suggests an imperative for integrated multi-disciplinary approaches that focus on medical and psychological aspects of patient care to enhance long-term well-being and quality of life.


Subject(s)
Carcinoma, Endometrioid , Depression , Endometrial Neoplasms , Fatigue , Quality of Life , Sleep Quality , Humans , Female , Fatigue/psychology , Endometrial Neoplasms/psychology , Endometrial Neoplasms/surgery , Endometrial Neoplasms/complications , Cross-Sectional Studies , Quality of Life/psychology , Middle Aged , Depression/psychology , Aged , Carcinoma, Endometrioid/psychology , Carcinoma, Endometrioid/surgery , Sleep Wake Disorders/psychology , Psychiatric Status Rating Scales , Sleep/physiology , Surveys and Questionnaires , Adult , Psychological Well-Being
2.
J Obstet Gynaecol ; 41(4): 621-625, 2021 May.
Article in English | MEDLINE | ID: mdl-32811229

ABSTRACT

Endometrial cancer is the most common gynaecologic malignancy in developed countries with increasing incidence worldwide. A total of 201 patients were enrolled and a cross-sectional study was performed using the European Organisation for Research and Treatment of Cancer quality of life questionnaire (EORTC QLQ-C30) and Female Sexual Functioning Index (FSFI) after the approval by an institutional review board (University of Health Sciences, Tepecik Education and Research Hospital, Turkey, March 13, 2019, Approval no. 2019/4-27). Morbidly obese patients (body mass index (BMI) ≥40 kg/m2) had lower physical functioning scores compared to non-obese (BMI < 30 kg/m2; p = .008) and non-morbidly obese patients (BMI < 40 kg/m2; p = .011). The overall sexual dysfunction rate was high (94.5%). No significant sexual function differences were observed among the study groups.IMPACT STATEMENTWhat is already known on this subject? Previous efforts to assess the influence of obesity and BMI on endometrial cancer patient quality of life have indicated that obesity adversely affects physical function and the effects of obesity on sexual function remains vague. In addition, the influence of patient age, surgical approach, adjuvant therapy type and time after diagnosis on quality of life and sexual function have not been clearly defined.What do the results of this study add? Increased BMI is associated with impaired physical function in endometrial cancer patients. However, BMI does not appear to affect sexual function in this population.What are the implications of these findings for clinical practice and/or further research? After endometrial cancer treatment, lifestyle interventions aimed at weight loss should be implemented to improve the quality of life.


Subject(s)
Cancer Survivors/psychology , Carcinoma, Endometrioid/psychology , Endometrial Neoplasms/psychology , Quality of Life/psychology , Sexual Behavior/psychology , Cross-Sectional Studies , Female , Functional Status , Humans , Middle Aged , Obesity/complications , Obesity/psychology , Surveys and Questionnaires , Turkey
3.
Int J Gynecol Cancer ; 20(8): 1367-73, 2010 Nov.
Article in English | MEDLINE | ID: mdl-21051979

ABSTRACT

OBJECTIVE: Evaluation of surgical outcomes, including quality of life, in patients with endometrial cancer in the early phase of implementation of a robotic surgery program, comparing elderly with younger patients. METHODS: Prospective evaluation of perioperative data and a postoperative quality-of-life survey of the first 100 robotic surgeries for endometrial cancer performed in the Division of Gynecologic Oncology at a tertiary cancer center. Women were divided in 2 groups based on age, allowing comparison of outcomes between the elderly (≥70 years) and younger groups (<70 years). RESULTS: Of the first 100 patients, 41 were elderly (mean age, 78 years). The elderly group had significantly higher number of comorbidities and more advanced disease when compared with the younger women. Despite this, elderly women had similar mean operative times (252 vs 243 minutes), mean console times (171 vs 175 minutes), and mean blood loss (83 vs 81 mL) as compared with the younger group. Conversion rate to minilaparotomy was 6%, all of which were performed at the end of surgery for the removal of enlarged uteri that could not be delivered vaginally. The overall perioperative complication rates were not statistically different between the age groups. Median hospital stay tended to be longer for the elderly women (2 vs 1 day) but was not statistically significant. The postoperative quality-of-life assessment revealed that patients young and old alike were highly satisfied with the procedure. CONCLUSIONS: Prospective evaluation indicates that even in the early phases of implementation of a robotic surgical program for endometrial cancer, the procedure seems safe and confers an excellent quality of life for elderly patients.


Subject(s)
Aged , Carcinoma, Endometrioid/surgery , Endometrial Neoplasms/surgery , Gynecologic Surgical Procedures/instrumentation , Quality of Life , Robotics , Adult , Age Factors , Aged, 80 and over , Carcinoma, Endometrioid/diagnosis , Carcinoma, Endometrioid/psychology , Cohort Studies , Endometrial Neoplasms/diagnosis , Endometrial Neoplasms/psychology , Female , Gynecologic Surgical Procedures/methods , Gynecologic Surgical Procedures/rehabilitation , Humans , Middle Aged , Minimally Invasive Surgical Procedures/rehabilitation , Prognosis , Robotics/methods , Treatment Outcome
4.
Anticancer Res ; 21(1B): 803-8, 2001.
Article in English | MEDLINE | ID: mdl-11299847

ABSTRACT

BACKGROUND: The objective of this study was to evaluate possible effects of a paclitaxel containing chemotherapy, on the central nervous system (CNS) in women with ovarian cancer. MATERIALS AND METHODS: Twenty-eight women with histologically documented epithelial ovarian carcinoma and treated with a combination chemotherapy consisting of paclitaxel and carboplatin entered the study. Patients were tested with resting EEG (R-EEG) before and after chemotherapy. RESULTS: Twenty of the 28 patients responded to the chemotherapy (71%). Eleven patients (39%) developed peripheral neurotoxicity. A decrease of beta power and an increase of delta and theta power as well as a deceleration of the total centroid frequency clearly demonstrated a reduced vigilance in patients with ovarian cancer compared to healthy controls. On the other hand, the observed increase of beta power, a decrease of delta and theta power, and an acceleration of the total centroid from pre- to post-treatment demonstrated an improvement of vigilance in patients with ovarian cancer after treatment with paclitaxel/carboplatin. CONCLUSIONS: The results of this study suggest that chemotherapy consisting of paclitaxel and carboplatin does not cause adverse effects on the central nervous system. Improved vigilance was measured in patients with ovarian cancer after chemotherapy.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/adverse effects , Brain Diseases/chemically induced , Electroencephalography/drug effects , Ovarian Neoplasms/drug therapy , Adenocarcinoma/drug therapy , Adenocarcinoma/psychology , Adenocarcinoma, Clear Cell/drug therapy , Adenocarcinoma, Clear Cell/psychology , Adult , Aged , Aged, 80 and over , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Brain Mapping , Carboplatin/adverse effects , Carboplatin/therapeutic use , Carcinoma, Endometrioid/drug therapy , Carcinoma, Endometrioid/psychology , Cognition Disorders/chemically induced , Dexamethasone/administration & dosage , Female , Humans , Middle Aged , Ovarian Neoplasms/psychology , Paclitaxel/adverse effects , Paclitaxel/therapeutic use , Peripheral Nervous System Diseases/chemically induced , Prospective Studies
SELECTION OF CITATIONS
SEARCH DETAIL
...